Persimmon Leaf Extract for Corneal Inflammation and Healing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for cornea damage and corneal diseases, such as keratitis, often fail to effectively inhibit inflammation and promote healing, leading to potential destruction of the cornea and significant vision impairment.

Innovation Solution

Administration of an effective amount of a persimmon tree extract, specifically a leaf extract of Diospyros kaki, in the form of a pharmaceutical or health food composition, which inhibits inflammatory cytokines, protects corneal cells, and promotes the proliferation of corneal epithelial cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional treatments for cornea damage are used, then the cornea may be protected from immediate destruction, but inflammation is not effectively inhibited and healing is not promoted

Engineering Contradiction:
Improvecornea protectionVSAvoidinflammation inhibition and healing promotion
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent changes the biochemical parameters of the treatment by using persimmon leaf extract containing specific compounds (kaempferol, quercetin, lutein) that modulate inflammatory cytokine expression and corneal cell proliferation, thereby simultaneously achieving inflammation inhibition and healing promotion

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs a composite therapeutic approach by combining multiple active compounds from persimmon leaf extract (kaempferol, quercetin, lutein) that work synergistically to inhibit inflammatory cytokines and promote corneal epithelial cell proliferation

Inventive Principle:
Principle #40Composite materials

2Reliability

If current cornea damage treatments are administered, then corneal destruction may be prevented, but significant vision impairment can still occur due to incomplete healing

Engineering Contradiction:
Improvecorneal destruction preventionVSAvoidvision impairment
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies preliminary protective action by administering persimmon leaf extract before complete corneal destruction occurs, utilizing its anti-inflammatory and proliferative properties to prevent both destruction and subsequent vision impairment through enhanced healing

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent converts the harmful inflammatory response into a beneficial healing process by using persimmon leaf extract to modulate inflammation, transforming the harmful cytokine storm into a controlled repair mechanism that prevents vision impairment

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Data Source

PatentUS9682113B2Method for preventing, improving or treating cornea damages using extracts of <i>Diospyros kaki</i>
Publication Date: 2017.06.20 KOREA INST OF SCI & TECH
  • US9682113B2 patent drawing
  • US9682113B2 patent drawing
  • US9682113B2 patent drawing

AI summary

Disclosed is a method for preventing, improving and/or treating cornea damage or a corneal disease, including administering an effective amount of an extract of a persimmon tree for preventing, improving or treating cornea damage to a subject in need thereof. The extract may be a persimmon leaf extract and the extract is effective in suppressing inflammation of the cornea and protecting corneal cells.